![Should all FMS-like (FLT3)-positive AML receive maintenance therapy post-allograft? – COSTEM Congress](https://oncodaily.com/pub/uploads/2024/08/GU19Q4JXEAAUF2Y.jpg)
Photo from COSTEM Congress/LinkedIn
Aug 13, 2024, 14:03
Should all FMS-like (FLT3)-positive AML receive maintenance therapy post-allograft? – COSTEM Congress
COSTEM Congress shared on X:
“We’re looking forward to hearing from Andreas Burchert and Arnon Nagler in the upcoming COSTEM congress – taking place in Berlin, Germany.
Register here and see full program here.”
Source: COSTEM Congress/X
The 9th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) will be held from October 24-27, 2024 in Berlin, Germany.
Aug 13, 2024, 13:16